LePure Biotech exhibited once again in Interphex 2022INTERPHEX brought the pharmaceutical manufacturing and biotech industries together at the 2022 show, taking place May 24 – 26 at the Javits Center. With its second event in seven months—the 2022 edition brought an increase in networking events, show floor programs, customer engagement and technical conference sessions.
Shanghai LePure Biotech exhibited among nearly 400 global suppliers. Several strategically released new products attracted wide attentions from industry professionals and visitors, especially LeKrius™ single-use bioprocess film and bags. The proprietary formulation ensures a fully controlled supply chain and excellent product performance.
During the exhibition, Dr. Jim Ding, Chief Scientific Officer of LePure Biotech and President of LePure US Branch (LePure Biotech LLC), delivered a keynote speech sharing in-depth technical information on LeKrius™ biopharmaceutical process film. Key benefits offered by LeKrius™ film include excellent bio safety (Safe), physical properties (Robustness) and stable quality and supply (Sustainability).
LePure Biotech was established in 2011. It pioneered localization of single-use solutions for biopharmaceutical industry in China. LePure has comprehensive capabilities in R&D, manufacturing, and commercial operation.
For 40+ years, INTERPHEX has proven to be the place to find all of the State-of-the-Art Solutions you need to Cost Effectively Develop and Manufacture Quality Product. INTERPHEX is the premier pharmaceutical, biotechnology, and device development and manufacturing event to “Experience Science through Commercialization.” Based in New York, INTERPHEX brings over 10,000 global industry professionals and 625+ leading suppliers together to “Learn It, Experience It, Procure It” through a combination of no cost technical conference, exhibits, demonstrations and networking events to leverage quality, efficiency and cost effectiveness in today’s global market.
